Neuronetics, Inc. (STIM)

USD 4.58

(2.69%)

Long Term Debt Summary of Neuronetics, Inc.

  • Neuronetics, Inc.'s latest annual long term debt in 2023 was 59.28 Million USD , up 129.81% from previous year.
  • Neuronetics, Inc.'s latest quarterly long term debt in 2024 Q2 was 46.14 Million USD , down -22.37% from previous quarter.
  • Neuronetics, Inc. reported annual long term debt of 25.79 Million USD in 2022, down -33.64% from previous year.
  • Neuronetics, Inc. reported annual long term debt of 38.87 Million USD in 2021, up 3.0% from previous year.
  • Neuronetics, Inc. reported quarterly long term debt of 46.14 Million USD for 2024 Q2, down -22.37% from previous quarter.
  • Neuronetics, Inc. reported quarterly long term debt of 39.35 Million USD for 2023 Q3, down -0.05% from previous quarter.

Annual Long Term Debt Chart of Neuronetics, Inc. (2023 - 2016)

Historical Annual Long Term Debt of Neuronetics, Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 59.28 Million USD 129.81%
2022 25.79 Million USD -33.64%
2021 38.87 Million USD 3.0%
2020 37.74 Million USD 67.61%
2019 22.51 Million USD -25.92%
2018 30.39 Million USD 2.84%
2017 29.55 Million USD 88.89%
2016 15.64 Million USD 0.0%

Peer Long Term Debt Comparison of Neuronetics, Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD -1828.53%
Applied DNA Sciences, Inc. 739.16 Thousand USD -7920.299%
Aspira Women's Health Inc. 1.43 Million USD -4045.664%
Biodesix, Inc. 35.22 Million USD -68.298%
BioNexus Gene Lab Corp. 98.76 Thousand USD -59925.516%
bioAffinity Technologies, Inc. 1.11 Million USD -5200.375%
bioAffinity Technologies, Inc. 1.11 Million USD -5200.375%
Bionano Genomics, Inc. 7.17 Million USD -726.244%
CareDx, Inc 28.27 Million USD -109.644%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 14.19 Million USD -317.545%
DarioHealth Corp. 24.59 Million USD -141.076%
Exact Sciences Corporation 2.47 Billion USD 97.605%
Fulgent Genetics, Inc. 10.11 Million USD -486.322%
Guardant Health, Inc. 1.13 Billion USD 94.8%
ICON Public Limited Company 3.66 Billion USD 98.383%
IDEXX Laboratories, Inc. 622.88 Million USD 90.482%
Illumina, Inc. 1.48 Billion USD 96.019%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -72797.3%
iSpecimen Inc. 29.13 Thousand USD -203411.843%
Standard BioTools Inc. 3.98 Million USD -1388.401%
MDxHealth SA 35.56 Million USD -66.694%
23andMe Holding Co. 67.84 Million USD 12.62%
Medpace Holdings, Inc. 142.12 Million USD 58.287%
Myriad Genetics, Inc. 130.9 Million USD 54.711%
Mainz Biomed B.V. 2.19 Million USD -2599.727%
ENDRA Life Sciences Inc. 192.06 Thousand USD -30766.595%
NeoGenomics, Inc. 606.06 Million USD 90.218%
Neogen Corporation 888.39 Million USD 93.327%
Inotiv, Inc. 399.4 Million USD 85.157%
Natera, Inc. 282.94 Million USD 79.048%
OPKO Health, Inc. 222.03 Million USD 73.3%
Psychemedics Corporation 945 Thousand USD -6173.333%
Prenetics Global Limited 867.21 Thousand USD -6736.021%
Prenetics Global Limited 867.21 Thousand USD -6736.021%
Precipio, Inc. 106 Thousand USD -55827.358%
Personalis, Inc. 1.23 Million USD -4704.133%
RadNet, Inc. 812.06 Million USD 92.7%
Sera Prognostics, Inc. 840 Thousand USD -6957.5%
Sotera Health Company 2.22 Billion USD 97.334%
Star Equity Holdings, Inc. 1.14 Million USD -5077.555%
Star Equity Holdings, Inc. 1.14 Million USD -5077.555%
Trinity Biotech plc 54.65 Million USD -8.476%
Twist Bioscience Corporation 79.17 Million USD 25.122%
Exagen Inc. 19.23 Million USD -208.268%